"While glyphosate will continue to play an important role in agriculture and in Bayer’s portfolio, the company is committed to offering more choices for growers," Bayer said in a statement on Friday.

Bayer said these measures seek to address public concerns arising from its acquisition of Monsanto, the maker of RoundUp, a glyphosate-based weedkiller which, according to thousands of U.S. plaintiffs, causes cancer. Bayer contests this.

(Reporting by Tassilo Hummel; Editing by Douglas Busvine)